These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 17332360)

  • 41. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors.
    Addison CL; Bramson JL; Hitt MM; Muller WJ; Gauldie J; Graham FL
    Gene Ther; 1998 Oct; 5(10):1400-9. PubMed ID: 9930346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenovirus-mediated expression of interleukin-12 induces natural killer cell activity and complements adenovirus-directed gp75 treatment of melanoma lung metastases.
    Hirschowitz EA; Crystal RG
    Am J Respir Cell Mol Biol; 1999 May; 20(5):935-41. PubMed ID: 10226063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of the natural killer cell repertoire: the sequential vs. the two-step selection model.
    Salmon-Divon M; Höglund P; Mehr R
    Bull Math Biol; 2003 Mar; 65(2):199-218. PubMed ID: 12675329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor cells expressing a fusion protein of MULT1 and Fas are rejected in vivo by apoptosis and NK cell activation.
    Kotturi HS; Li J; Branham-O'Connor M; Stickel SL; Yu X; Wagner TE; Wei Y
    Gene Ther; 2008 Oct; 15(19):1302-10. PubMed ID: 18463688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
    Nokihara H; Yanagawa H; Nishioka Y; Yano S; Mukaida N; Matsushima K; Sone S
    Cancer Res; 2000 Dec; 60(24):7002-7. PubMed ID: 11156403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis.
    Kundu N; Fulton AM
    Cell Immunol; 1997 Aug; 180(1):55-61. PubMed ID: 9316639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination.
    Cheng WF; Hung CF; Lin KY; Ling M; Juang J; He L; Lin CT; Wu TC
    Gene Ther; 2003 Aug; 10(16):1311-20. PubMed ID: 12883527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activated T-cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell non-Hodgkin lymphoma.
    Mihara K; Yanagihara K; Takigahira M; Imai C; Kitanaka A; Takihara Y; Kimura A
    J Immunother; 2009 Sep; 32(7):737-43. PubMed ID: 19561535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
    Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
    Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells.
    Geutskens SB; van der Eb MM; Plomp AC; Jonges LE; Cramer SJ; Ensink NG; Kuppen PJ; Hoeben RC
    Gene Ther; 2000 Aug; 7(16):1410-6. PubMed ID: 10981668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
    Zhang AL; Russell PJ; Knittel T; Milross C
    Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras-transformed cells.
    Tsuruma T; Yagihashi A; Torigoe T; Sato N; Kikuchi K; Watanabe N; Hirata K
    Cell Immunol; 1998 Mar; 184(2):121-8. PubMed ID: 9630838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapy.
    Parkinson RJ; Mian S; Bishop MC; Gray T; Li G; McArdle SE; Ali S; Rees RC
    Prostate; 2003 Jun; 56(1):65-73. PubMed ID: 12746848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models.
    Lanuti M; Rudginsky S; Force SD; Lambright ES; Siders WM; Chang MY; Amin KM; Kaiser LR; Scheule RK; Albelda SM
    Cancer Res; 2000 Jun; 60(11):2955-63. PubMed ID: 10850443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro.
    Mammolenti M; Gajavelli S; Tsoulfas P; Levy R
    Stem Cells; 2004; 22(6):1101-10. PubMed ID: 15536199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity.
    Chen Y; DeWeese T; Dilley J; Zhang Y; Li Y; Ramesh N; Lee J; Pennathur-Das R; Radzyminski J; Wypych J; Brignetti D; Scott S; Stephens J; Karpf DB; Henderson DR; Yu DC
    Cancer Res; 2001 Jul; 61(14):5453-60. PubMed ID: 11454691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells.
    Sanchez-Perez L; Gough M; Qiao J; Thanarajasingam U; Kottke T; Ahmed A; Thompson JM; Maria Diaz R; Vile RG
    Gene Ther; 2007 Jul; 14(13):998-1009. PubMed ID: 17443216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autologous lymphocyte responses to adenovirus-B7-1-transduced human cancer cells.
    Dessureault S; Graham FL; Gallinger S
    Cancer Gene Ther; 1999; 6(3):195-208. PubMed ID: 10359205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma.
    Schmitz V; Barajas M; Wang L; Peng D; Duarte M; Prieto J; Qian C
    Hepatology; 2001 Jul; 34(1):72-81. PubMed ID: 11431736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor-suppressive activity of CD66a in prostate cancer.
    Luo W; Tapolsky M; Earley K; Wood CG; Wilson DR; Logothetis CJ; Lin SH
    Cancer Gene Ther; 1999; 6(4):313-21. PubMed ID: 10419049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.